CareTrust REIT (CTRE) Gets a Buy Rating from KeyBanc

KeyBanc analyst Josh Beck maintained a Buy rating on CareTrust REIT (CTREResearch Report) today and set a price target of $21.00. The company’s shares closed last Wednesday at $18.89.

According to, Beck is a 5-star analyst with an average return of 16.6% and a 57.1% success rate. Beck covers the Technology sector, focusing on stocks such as BigCommerce Holdings, AvidXchange Holdings, and Robinhood Markets.

The word on The Street in general, suggests a Hold analyst consensus rating for CareTrust REIT with a $19.90 average price target.

See the top stocks recommended by analysts >>

Based on CareTrust REIT’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $46.01 million and GAAP net loss of $43.26 million. In comparison, last year the company earned revenue of $45.25 million and had a net profit of $20.49 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CareTrust REIT, Inc. operates as real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.

Read More on CTRE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More